Jean-François Mosnier Selected Research

Biomarkers (Surrogate Marker)

3/2022	Serum Pepsinogens Combined with New Biomarkers Testing Using Chemiluminescent Enzyme Immunoassay for Non-Invasive Diagnosis of Atrophic Gastritis: A Prospective, Multicenter Study.
10/2020	A panel of stomach-specific biomarkers (GastroPanel®) for the diagnosis of atrophic gastritis: A prospective, multicenter study in a low gastric cancer incidence area.
2/2009	N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-François Mosnier Research Topics

Disease

13	Neoplasms (Cancer) 01/2021 - 02/2002
8	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 06/2007
8	Adenocarcinoma 03/2022 - 08/2007
7	Carcinoma (Carcinomatosis) 03/2022 - 10/2005
7	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 10/2006
5	Inflammation (Inflammations) 01/2019 - 01/2006
4	Atrophic Gastritis 01/2024 - 10/2020
3	Infections 04/2023 - 01/2005
3	Mucinous Adenocarcinoma (Mucinous Carcinoma) 03/2022 - 11/2007
3	Hyperplasia 01/2022 - 02/2003
3	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2008
3	Crohn Disease (Crohn's Disease) 10/2015 - 08/2009
2	Stomach Neoplasms (Stomach Cancer) 03/2022 - 10/2020
2	Autoimmune Hepatitis 12/2020 - 05/2002
2	Microsatellite Instability 01/2017 - 09/2007
2	Carcinogenesis 01/2017 - 10/2007
2	Ulcerative Colitis 03/2015 - 08/2009
2	Colitis 08/2009 - 12/2007
2	Fibrosis (Cirrhosis) 02/2009 - 05/2002
2	Colonic Neoplasms (Colon Cancer) 08/2007 - 06/2007
1	Iron Deficiencies 01/2024
1	Gastritis 01/2024
1	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 01/2024
1	Ovarian Neoplasms (Ovarian Cancer) 11/2023
1	Myositis (Idiopathic Inflammatory Myopathies) 04/2023
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 03/2022
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 12/2020
1	Virus Diseases (Viral Diseases) 10/2018
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2018
1	Lymphoma (Lymphomas) 10/2018
1	Deglutition Disorders (Dysphagia) 02/2018
1	Primitive Neuroectodermal Tumors (PNET) 07/2017
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 07/2017
1	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2014

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 03/2022 - 02/2002
4	Cadherins (E-Cadherin)IBA 04/2014 - 04/2006
4	Messenger RNA (mRNA)IBA 01/2012 - 10/2005
3	AutoantibodiesIBA 04/2023 - 05/2002
3	Biomarkers (Surrogate Marker)IBA 03/2022 - 02/2009
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2009 - 01/2006
3	S100 Proteins (S 100 Protein)IBA 08/2009 - 02/2002
2	IronIBA 01/2024 - 05/2002
2	Pepsinogen A (Pepsinogen)IBA 10/2023 - 03/2022
2	EnzymesIBA 03/2022 - 07/2017
2	beta CateninIBA 03/2022 - 10/2007
2	Calcibiotic Root Canal SealerIBA 03/2022 - 09/2007
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2013
2	IntegrinsIBA 01/2019 - 01/2012
2	MethyltransferasesIBA 07/2017 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 07/2017 - 09/2007
2	CytokinesIBA 10/2015 - 08/2009
2	Keratin-7 (Cytokeratin 7)IBA 04/2015 - 02/2009
2	LigandsIBA 10/2007 - 08/2007
2	tau Proteins (tau Protein)IBA 02/2003 - 02/2002
1	MicronutrientsIBA 01/2024
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2024
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2023
1	AntibodiesIBA 04/2023
1	Intrinsic Factor FDA Link 04/2023
1	Ferritins (Ferritin)IBA 03/2022
1	Interleukin-6 (Interleukin 6)IBA 03/2022
1	AdiponectinIBA 03/2022
1	PepsinogensIBA 03/2022
1	defibrotideIBA 01/2022
1	monalizumabIBA 01/2021
1	Bispecific AntibodiesIBA 01/2021
1	Cetuximab (Erbitux)FDA Link 01/2021
1	liver antigen LA-1IBA 12/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 11/2020
1	ChemokinesIBA 11/2020
1	Immune Checkpoint InhibitorsIBA 11/2020
1	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 01/2019
1	Interleukin-7 (Interleukin 7)IBA 01/2019
1	Peptides (Polypeptides)IBA 10/2018
1	Interferon LambdaIBA 10/2018
1	Double-Stranded RNA (RNA, Double Stranded)IBA 10/2018
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 10/2018
1	Small Interfering RNA (siRNA)IBA 10/2018
1	antineoplaston A10 (A 10)IBA 02/2018
1	Alkylating AgentsIBA 07/2017
1	Temozolomide (Temodar)FDA LinkGeneric 07/2017
1	A-Form DNA (A-DNA)IBA 07/2017
1	Interleukin-18 (Interleukin 18)IBA 10/2015
1	InflammasomesIBA 10/2015
1	1-(propoxymethyl)maleimideIBA 04/2015
1	Keratin-20 (Cytokeratin 20)IBA 04/2015
1	Differentiation AntigensIBA 04/2015
1	Indicators and Reagents (Reagents)IBA 03/2015
1	Mitochondrial DNA (mtDNA)IBA 03/2015
1	Capsules (Microcapsules)IBA 06/2014
1	MucinsIBA 01/2013
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2013
1	Capecitabine (Xeloda)FDA Link 01/2013

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 01/2022 - 02/2004
2	Immunotherapy 11/2020 - 01/2020
2	Lasers (Laser) 03/2015 - 06/2014
2	Pancreatectomy 02/2010 - 11/2008
1	Therapeutics 01/2017
1	Chemoradiotherapy 01/2013